For immediate release. Vancouver, British Columbia, March 2, 2015:Cannabix Technologies Inc.(CSE: BLO, OTC PINK: BLOZF) (the “Company”) is pleased to announce it has produced an Alpha version of the Cannabix Marijuana Breathalyzer prototype. Fabrication of prototype parts, creation of firmware, circuit boards, electronics and detection modules are all completed in the Alpha version. The Alpha version of the Cannabix Marijuana Breathalyzer has been developed in concert with KLN Klein Product Development Inc. of Vancouver, B.C.

The Company will now begin testing the device internally with medical marijuana users. In addition, the Company is continuing to work with consultants and scientists to maximize THC sensitivity, detection and reliability of the device for use as a roadside or workplace drug impairment tool.

Further modifications may be made to enhance a range of components that make up the device including optimization of THC detection levels, weather proofing, calibration methods and other features. After internal testing and development is complete with the Alpha prototype, the Company will look to release a Beta version for trial testing with external organizations. Trial testing externally (with independent agencies) will help determine reliability, functionality and accuracy of the device within a larger population of potential end users.

Kal Malhi, President of Cannabix Technologies stated, “We have initiated our internal testing of the Alpha version of the breathalyzer prototype. We are also excited to have commenced discussions with suitable organizations for trial testing.”